Brainstem death
Brainstem death is a clinical syndrome defined by the absence of reflexes with pathways through the brainstem. The diagnosis of brainstem death is based on clinical criteria that vary internationally. In some countries, brainstem death is equivalent to death, and in others, it is a prerequisite for the diagnosis of death.
Definition[edit]
Brainstem death is defined as the irreversible loss of all functions of the brainstem. This includes the loss of all cranial nerve reflexes and the inability to breathe spontaneously. The diagnosis is clinical and does not rely on any specific investigations.
Pathophysiology[edit]
The brainstem is responsible for maintaining consciousness and controlling most involuntary functions necessary for life, such as breathing and heart rate. When the brainstem is damaged, these functions can be lost. The most common causes of brainstem death are traumatic brain injury, stroke, and brain tumors.
Diagnosis[edit]
The diagnosis of brainstem death is based on clinical criteria. These include the absence of all brainstem reflexes, such as pupillary light reflex, corneal reflex, and gag reflex. The patient must also be unable to breathe spontaneously, which is tested by an apnea test.
Implications[edit]
The diagnosis of brainstem death has significant implications. It allows for the withdrawal of life-sustaining treatments and the possibility of organ donation. In some countries, brainstem death is legally equivalent to death.
Controversies[edit]
There are controversies surrounding the concept of brainstem death. Some argue that the criteria for diagnosis are not universally accepted and that there is a lack of standardization in testing. Others question whether brainstem death is truly equivalent to death.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian